Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Dabigatran Etexilate in Healthy Chinese Subjects
NCT02171572Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of dabigatran in thromboembolism (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Changes in physical examination at Day 14, Changes in vital signs and 3 more. Started Oct 2009; status: completed.
02
Drugs
dabigatran
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02171572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02171572.